MedTrace Logo

LMA Unique TM & the Self Pressurized Air-Q TM Intubating Laryngeal Airway in Children

NCT01385761 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2012-03-13

No results posted yet for this study

Summary

The purpose of this study is to compare the clinical efficacy of the air-Q ILA-SP with the current standard of care, the LMA Unique in anesthetized non-paralyzed pediatric patients.

Conditions

  • Children

Interventions

DEVICE

Laryngeal Mask Airway

Each child will be randomized to either receiving the LMA or air-Q ILA-SP as their supraglottic airway device for primary airway maintenance.

DEVICE

air-QTM Intubating Laryngeal Airway

Each child will be randomized to either receiving the LMA or air-Q ILA-SP as their supraglottic airway device for primary airway maintenance.

Sponsors & Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

    lead OTHER

Principal Investigators

  • Narasimhan Jagannathan, MD · Childrens Memorial Hospital

Eligibility

Min Age
3 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01385761 on ClinicalTrials.gov